Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Sexually Transmitted Diseases

Free Subscription Articles published in J Virol Retrieve available abstracts of 24 articles: HTML format

Single Articles

September 2025
1. RENNER J, Boldt K, Wieland A, Grundhoff A, et al
   Activation of the HPV16 late promoter by viral E2 and cellular BRD4 and ZC3H4 proteins.
   J Virol. 2025;99:e0076225.
   PubMed     Abstract available
   
   
   August 2025
2. BILLINGSLEY CL, Doud EH, Smith-Kinnaman W, Mosley AL, et al
   Proliferative proteome induced by HPV 16E6 and NFX1-123 partnership in longitudinal keratinocyte cultures.
   J Virol. 2025 Aug 13:e0096725. doi: 10.1128/jvi.00967.
   PubMed     Abstract available
   
   
   July 2025
3. IBRAGIMOV R, Babok S, Lototskaja-Perepelenko E, Ivanova L, et al
   Targeting papillomavirus infections: high-throughput screening reveals an effective inhibitor of cutaneous beta-HPV types.
   J Virol. 2025 Jul 8:e0091825. doi: 10.1128/jvi.00918.
   PubMed     Abstract available
   
   
   March 2025
4. GBALA I, Kavcic N, Banks L
   The retinoblastoma protein contributes to maintaining the stability of HPV E7 in cervical cancer cells.
   J Virol. 2025 Mar 25:e0220324. doi: 10.1128/jvi.02203.
   PubMed     Abstract available
   
   
   January 2025
5. KEIFFER TR, DiGiuseppe S, Guion L, Bienkowska-Haba M, et al
   HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis.
   J Virol. 2025;99:e0093724.
   PubMed     Abstract available
   
   
   October 2024
6. SCHAAL DL, Amucheazi AA, Jones SC, Nkadi EH, et al
   Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors.
   J Virol. 2024;98:e0099524.
   PubMed     Abstract available
   
   
   
7. JONSSON J, Zhai Q, Schwartz S, Kajitani N, et al
   hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6;E7 mRNAs via GGG motifs.
   J Virol. 2024;98:e0095124.
   PubMed     Abstract available
   
   
   
8. JAMES CD, Lewis RL, Fakunmoju AL, Witt AJ, et al
   Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses.
   J Virol. 2024;98:e0102424.
   PubMed     Abstract available
   
   
   
9. PENG Y, Wang W, Liu X, Li S, et al
   Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
   J Virol. 2024;98:e0067724.
   PubMed     Abstract available
   
   
   September 2024
10. JAMES CD, Youssef A, Prabhakar AT, Otoa R, et al
    Human papillomavirus 16 replication converts SAMHD1 into a homologous recombination factor and promotes its recruitment to replicating viral DNA.
    J Virol. 2024;98:e0082624.
    PubMed     Abstract available
    
    
    July 2024
11. JOSE L, Smith K, Crowner A, Androphy EJ, et al
    Senataxin mediates R-loop resolution on HPV episomes.
    J Virol. 2024 Jul 24:e0100324. doi: 10.1128/jvi.01003.
    PubMed     Abstract available
    
    
    June 2024
12. BRONIARCZYK J, Trejo-Cerro O, Massimi P, Kavcic N, et al
    HPV-18 E6 enhances the interaction between EMILIN2 and SNX27 to promote WNT signaling.
    J Virol. 2024 Jun 14:e0073524. doi: 10.1128/jvi.00735.
    PubMed     Abstract available
    
    
    May 2024
13. CHEN L, Hu H, Pan Y, Lu Y, et al
    The role of HPV11 E7 in modulating STING-dependent interferon beta response in recurrent respiratory papillomatosis.
    J Virol. 2024;98:e0192523.
    PubMed     Abstract available
    
    
    April 2024
14. QUADIRI A, Prakash S, Dhanushkodi NR, Singer M, et al
    Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4(+) and CD8(+) T cells and protects against recurrent
    J Virol. 2024 Apr 8:e0159623. doi: 10.1128/jvi.01596.
    PubMed     Abstract available
    
    
    February 2024
15. KHALIL MI, Yang C, Vu L, Chadha S, et al
    The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    J Virol. 2024;98:e0172623.
    PubMed     Abstract available
    
    
    October 2023
16. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Direct interaction with the BRD4 carboxyl-terminal motif (CTM) and TopBP1 is required for human papillomavirus 16 E2 association with mitotic chromatin and plasmid segregation function.
    J Virol. 2023;97:e0078223.
    PubMed     Abstract available
    
    
    September 2023
17. BOURNE N, Keith CA, Miller AL, Pyles RB, et al
    Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    J Virol. 2023;97:e0066923.
    PubMed     Abstract available
    
    
    August 2023
18. MORI S, Ishii Y, Takeuchi T, Kukimoto I, et al
    Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    J Virol. 2023;97:e0081523.
    PubMed     Abstract available
    
    
    June 2023
19. ZWOLINSKA K, Bienkowska-Haba M, Scott RS, Keiffer T, et al
    Experimental Support for Human Papillomavirus Genome Amplification Early after Infectious Delivery.
    J Virol. 2023;97:e0021423.
    PubMed     Abstract available
    
    
    
20. LOTOTSKAJA E, Liblekas L, Piirsoo M, Laanevali A, et al
    Phosphorylation of E2 Serine Residue 402 Is Required for the Transcription and Replication of the HPV5 Genome.
    J Virol. 2023;97:e0064323.
    PubMed     Abstract available
    
    
    May 2023
21. ISHII Y, Yamaji T, Sekizuka T, Homma Y, et al
    Folliculin Prevents Lysosomal Degradation of Human Papillomavirus To Support Infectious Cell Entry.
    J Virol. 2023;97:e0005623.
    PubMed     Abstract available
    
    
    March 2023
22. PRABHAKAR AT, James CD, Fontan CT, Otoa R, et al
    Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle.
    J Virol. 2023;97:e0006323.
    PubMed     Abstract available
    
    
    
23. CHEN J, Wang D, Wang Z, Wu K, et al
    Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    J Virol. 2023;97:e0181922.
    PubMed     Abstract available
    
    
    February 2023
24. BIENKOWSKA-HABA M, Zwolinska K, Keiffer T, Scott RS, et al
    Human Papillomavirus Genome Copy Number Is Maintained by S-Phase Amplification, Genome Loss to the Cytosol during Mitosis, and Degradation in G(1) Phase.
    J Virol. 2023;97:e0187922.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.